3626 results for «557»
3626 results
Transcatheter mitral valve-in-valve intervention and paravalvular leak closure
18 Nov 2019 – From PCR London Valves 2019
Consult this session on transcatheter mitral valve-in-valve intervention and paravalvular leak closure to discover a selection of challenging cases, such as: percutaneous mitral-in-ring implantation with a new-generation balloon-expandable valve via transseptal approach, multiple mitral paravalvular leaks closure as a bridge to surgery, direct access transcatheter mitral...
Valve for Life @ PCR London Valves 2019
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the importance of valvular heart disease across countries in Europe, the EAPCI goals for transcatheter heart valve interventions and the actions supported by the Valve for Life initiative.
TAVI: stroke, cerebral protection and alternative vascular access
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover the results of various TAVI trials and studies, and learn more about stroke, cerebral embolic protection and alternative vascular access.
Transforming patient access and care for valvular heart disease
17 Nov 2019 – From PCR London Valves 2019
Consult this session on valvular heart disease to learn about the current and future patient transcatheter treatment options and the future challenges they bring for the heart teams, and discover the importance of valve design choice for the patient's future.
TAVI complications and challenging vascular access
18 Nov 2019 – From PCR London Valves 2019
Shockwave IVL: a new alternative to alternative TAVI access
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn about new options for alternative TAVI access to cope with most challenges, as well as various approaches to patient selection. Gain insight also into how intravascular lithotripsy may be an option to preserve transfemoral TAVI, with a selection of clinical cases and...
Spotlight - Challenges for the Heart Team I - A new interventional paradigm for aortic valve disease
18 Nov 2019 – From PCR London Valves 2019
Consult this session on aortic valve disease to learn more about the impact of the latest evidence concerning TAVI vs. SAVR on Heart Team discussions and patient choice (clinical and anatomical characteristics, redistribution of resources and training...), and discover how you and your colleagues can apply this information in...
Increasing safety in complex TAVI procedures
18 Nov 2019 – From PCR London Valves 2019
Consult this session to review the current data on cerebral embolic protection during TAVI, to learn about different options for complex TAVI procedures and to discover future options for transcatheter mitral valve repair, thanks to a selection of various studies and challenging clinical cases.
TAVI: predicting the need for permanent pacing
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about how to predict the need for permanent pacemaker implantation after TAVI, thanks to a selection of studies regarding novel anatomic predictors, newer MDCT measurements, and more!
Challenging clinical scenarios in valve interventions - Hosted by Germany, Spain and Singapore
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover various challenging clinical cases and complications in valve interventions, such as MitraClip for cardiogenic shock, repositionning of a dislodged ALLEGRA transcatheter aortic valve, delayed coronary obstruction, percutaneous closure of a posterior leaflet perforation, and more!
Innovations in TAVI technique and technology to address evolving patient needs
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the innovations in TAVI technique and technology, adapting to the changing needs of younger and lower risk patients, and discover how to optimise TAVI procedural outcomes and minimise the need for permanent pacemaker implantation and how to use Evolut PRO+ valve...
A team approach to the management of tricuspid regurgitation
Consult this session to learn all about tricuspid valve disease: anatomy, imaging, guideline-directed treatment, and discover new transcatheter treatment options for tricuspid regurgitation, as well as the specific advantages of the Edwards Cardioband tricuspid valve reconstruction system for your patients.
TAVI: clinical outcomes with new devices and delivery systems
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI to learn more about the clinical outcomes with new devices and delivery systems, such as the self-expandable Portico valve, the Portico IDE FlexNav delivery system, the SAPIEN 3 Ultra system, and more!
Case-based learning for the Heart Valve team: TAVI failure - What are the options?
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the detection and management of structural valve deterioration and bioprosthetic valve failure, and discover the key role of imaging in patient assessment, with a selection of challenging clinical cases: a TAVI patient with structural valve deterioration, another one with infective endocarditis, and more!
Complications of surgical and transcatheter valve interventions: the case that taught me most
19 Nov 2019 – From PCR London Valves 2019
Consult this session on the complications of surgical and transcatheter valve interventions to learn tips and tricks from high-volume experienced operators, and to discover techniques for an effective prevention and management of life-threatening complications.
Everything you should know to perform a transcatheter valve in valve procedure
22 Nov 2020 – From PCR Valves e-course 2020
Watch this session if you want to understand what are the key criteria to be considered when choosing a THV, especially in patients with expected longer life expectancy, to learn about how to successfully perform Valve-in-surgical-valve procedures and to understand about key procedural aspects to consider...
Tricuspid percutaneous repair
22 Nov 2020 – From PCR Valves e-Course 2020
Learn more about combined percutaneous mitral and tricuspid repair as well as percutaneous repair of isolated tricuspid regurgitation using MitraClip.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
